Vestcor Inc’s Fulgent Genetics FLGT Stock Holding History

Vestcor Inc’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-6,268	Closed	-$196K	–	1102
2023 Q1	$196K	Sell	6,268 -1,200	-16%	-$38.6K	0.01%	897
2022 Q4	$222K	Buy	+7,468	New	+$267K	0.01%	896

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Vestcor Inc's FLGT Position: Q2 2023 in Review

Vestcor Inc sold out of Fulgent Genetics (FLGT) in Q2 2023, closing a stake of 6,268 shares — an estimated $196K sold.

Vestcor Inc first reported a position in FLGT in Q4 2022 and held it in 2 quarters. The position peaked at $222K in Q4 2022. 214 funds tracked by Wall St. Rank hold FLGT as of Q2 2023.

Vestcor Inc reported no remaining Fulgent Genetics position as of Q2 2023 after selling out during the quarter.
Vestcor Inc sold 6,268 Fulgent Genetics shares in Q2 2023, an estimated $196K.
Vestcor Inc first reported a position in Fulgent Genetics in Q4 2022 and held it in 2 quarters.
Vestcor Inc's Fulgent Genetics position peaked at $222K in Q4 2022.
214 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2023.

Based on Vestcor Inc's 13F filing for Q2 2023, filed 15 Aug 2023.